Omrix Biopharmaceuticals, Inc. (NASDAQ:OMRI)
24.99
-0 (-0%)
| Omrix Biopharmaceuticals, Inc. (NASDAQ:OMRI) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $24.99 | 52 Week High | $25.04 | ||
| Open | $24.99 | 52 Week Low | $8.99 | ||
| Day High | $24.99 | P/E | 36.22 | ||
| Day Low | $24.99 | EPS | $0.69 | ||
| Volume | 144,828 | ||||
| More OMRI Info: Chart SEC Filings Profile Historical Options | |||||
Entities who have mentioned OMRI
- JPMorgan | View Related Stories »
- UBS | View Related Stories »
- Merrill Lynch | View Related Stories »
- Wachovia | View Related Stories »
- Banc of America | View Related Stories »
- Bear Stearns | View Related Stories »
- Bankruptcy | View Related Stories »
- Lehman Brothers | View Related Stories »
- Apollo Management | View Related Stories »
- Citi | View Related Stories »
- Bain Capital | View Related Stories »
- Wellspring Capital Management | View Related Stories »
- Hellman & Friedman LLC | View Related Stories »
- Barclays | View Related Stories »
- Aurora Capital Group | View Related Stories »
- Soleil Securities | View Related Stories »
- Goldman Sachs | View Related Stories »
- Morgan Stanley | View Related Stories »
- Notable Mergers and Acquisitions | View Related Stories »
- Brean Murray Carret & Co. | View Related Stories »
- Keefe, Bruyette & Woods | View Related Stories »
- Raymond James | View Related Stories »
- Canaccord Adams | View Related Stories »
- Top 15 For 2008 | View Related Stories »
- Morgan Joseph | View Related Stories »
StreetInsider Reports on OMRI by Category
View All BlogsBlogs on OMRI
- Google: A Gorilla Not to Be Missed
- 40 Top Rated Emerging Bio-Pharma Stocks
- Breast implant maker stock expands 90%
- Breast implant maker stock expands 90%
- Omrix Gets Acquired By J&J (OMRI, JNJ)
Comments on recent OMRI articles
Comments on OMRI
No comments are currently available.
on Jan 2, 2009
at 03:04 PM Despite Lehman failure... Hats off to the Wall Street gurus who pulled off deals despite the carnage for example Teva's successful takeover of Barr was represented by Lehman until the venerable finance house went belly up. Nevertheless the deal close on time.
Article: Top 15 For 2008 (No. 14): M&A Wreckage